Abstract Details
|
Martin Rakusa, MD
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Dafin F. Muresanu, MD, PhD (Ebewe Pharma Romania) | No disclosure on file |
| No disclosure on file | |
| Pieter E. Vos, MD, PhD (Slingeland Hospital) | No disclosure on file |
| Jack P. Antel, MD, FÂé¶¹´«Ã½Ó³» (Montreal Neurologic Hospital) | Dr. Antel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi, roche, biogen, wave,nervgen. The institution of Dr. Antel has received research support from Novartis canada bristol myers squib. Dr. Antel has a non-compensated relationship as a past president with ACTRIMS that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |